Conference Track

Highlight on Special Hepatic Issues and Populations

Source: CCO Independent Conference Coverage of the 2008 Annual Meeting of the European Association for the Study of the Liver*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Capsule Summaries

5 Chronic Hepatitis C–Related Hepatocellular Carcinoma Subclasses Identified by Integrative Genomic Analysis
Y90 Glass Microsphere Radioembolization for Inoperable HCC Patients Shows Promising Safety and Survival in Single-Center Study
Pilot Study: Sirolimus Appears Safe, Effective for Decreasing Tumor Growth in Cirrhotic Patients With Advanced HCC
Combination of Biomarkers Successfully Identifies Patients With Nonalcoholic Steatohepatitis
Simvastatin Reduces Portal Hypertension in Patients With Cirrhosis
No Correlation Found Between HBV Infection and Insulin Resistance in Indian Cohort
Risk Score Predicts Long-term Probability of HCC Development
Higher Biochemical Remission Rates, Fewer Adverse Events With Budesonide vs Prednisone for the Treatment of AIH
Sorafenib Improves Clinical Outcome in Advanced HCC Regardless of Previous Therapy
TRIC-1 Study: Metformin Added to Peginterferon alfa-2a and Ribavirin Improves RVR Rate in Treatment-Naive Genotype 1 HCV Patients With Insulin Resistance

Expert Analysis

Highlight on Special Hepatic Issues and Populations

Faculty:
Robert G. Gish, MD Josep M. Llovet, MD Paul Martin, MD

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss recent data concerning insulin resistance and viral hepatitis
Describe new insights into management strategies for patients with hepatocellular carcinoma and those undergoing liver transplantation
Recount developing strategies for the management of autoimmune hepatitis
Recount recent data concerning noninvasive approaches to the assessment of nonalcoholic fatty liver disease

CME CREDIT INFORMATION

Release Date: 06/23/08

Expiration Date: 06/22/09

Physicians: maximum of 1.25 AMA PRA Category 1 Credit(s)™

Pharmacists: 1.3 contact hours (0.13 CEUs)

Registered Nurses: 1.3 Nursing CE credits

Status: Please log in to view status

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.